{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:05:15Z","timestamp":1792555515869,"version":"4.5.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1111\/j.1524-4725.2006.32330.x","type":"journal-article","created":{"date-parts":[[2007,1,3]],"date-time":"2007-01-03T10:43:04Z","timestamp":1167820984000},"page":"S37-S43","source":"Crossref","is-referenced-by-count":114,"title":["Pilot Study Comparing the Diffusion of Two Formulations of Botulinum Toxin Type A in Patients with Forehead Hyperhidrosis"],"prefix":"10.1097","volume":"33","author":[{"given":"ADA R.","family":"TRINDADE DE ALMEIDA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELISA","family":"MARQUES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JANETE","family":"DE ALMEIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THAIS","family":"CUNHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROSANA","family":"BORASO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20231117","first-page":"1651","article-title":"A comparison of two botulinum type A toxin preparations for the treatment of glabellar lines","volume":"31","author":"Lowe","year":"2005","journal-title":"double-blind, randomized, pilot study"},{"key":"R3-7-20231117","first-page":"A212","article-title":"Comparison of the therapeutic windows of different botulinum neurotoxin preparations in an animal model","volume":"60","author":"Aoki","year":"2003","journal-title":"Neurology"},{"key":"R4-7-20231117","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0041-0101(01)00101-5","article-title":"A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice","volume":"39","author":"Aoki","year":"2001","journal-title":"Toxicon"},{"key":"R5-7-20231117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870090106","article-title":"Histologic assessment of dose\u2010related diffusion and muscle fiber response after therapeutic botulinum A toxin injections","volume":"9","author":"Borodic","year":"1994","journal-title":"Mov Disord"},{"key":"R6-7-20231117","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1517\/13543784.6.10.1383","article-title":"The therapeutic use of botulinum toxin","volume":"6","author":"Tugnoli","year":"1997","journal-title":"Expert Opin Invest Drugs"},{"key":"R7-7-20231117","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/archderm.140.11.1351","article-title":"Effect of volume and concentration on the diffusion of botulinum exotoxin A","volume":"140","author":"Hsu","year":"2004","journal-title":"Arch Dermatol"},{"key":"R8-7-20231117","first-page":"1158","article-title":"Botulinum toxin treatment in the facial muscles of humans","volume":"46","author":"Eleopra","year":"1996","journal-title":"evidence of an action in untreated near muscles by peripheral local diffusion"},{"key":"R9-7-20231117","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00941758","article-title":"Comparison of two botulinum\u2010toxin preparations in the treatment of essential blepharospasm","volume":"235","author":"N\u00fcssgens","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-7-20231117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000048297","article-title":"Effect of botulinum toxin A on facial wrinkle lines in Koreans","volume":"216","author":"Lew","year":"2002","journal-title":"Ophthalmologica"},{"key":"R11-7-20231117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","volume":"64","author":"Odergren","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R12-7-20231117","first-page":"71","article-title":"Botulinum toxin type A","volume":"20","author":"Carruthers","year":"2001","journal-title":"history and current cosmetic use in the upper face"},{"key":"R13-7-20231117","first-page":"AB2","article-title":"Diffusion, dispersion, or action halos of botulinum toxins? A pilot study comparing two commercial preparations of type A botulinum toxins [Abstract 153\u201006]","volume":"52","author":"Hexsel","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R15-7-20231117","first-page":"519","article-title":"Botulinum toxin type B (Myobloc) versus botulinum toxin type A (Botox) frontalis study","volume":"29","author":"Flynn","year":"2003","journal-title":"rate of onset and radius of diffusion"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042728-200701001-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:21:34Z","timestamp":1786033294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-200701001-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":13,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2006.32330.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1066959.519926","asserted-by":"object"}]},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}